David M. Wyatt
Biberach An Der Riss, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Epigenetic dysregulation of IRF9 drives excessive interferon signaling in COPD.
Journal: EMBO molecular medicine
Published: August 12, 2025
Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 30, 2025
AAV-mediated expression of a new conformational anti-aggregated α-synuclein antibody prolongs survival in a genetic model of α-synucleinopathies.
Journal: NPJ Parkinson's disease
Published: December 02, 2022
opnMe.com: a digital initiative for sharing tools with the biomedical research community.
Journal: Nature reviews. Drug discovery
Published: April 23, 2022
Screening for Inhibitors of YAP Nuclear Localization Identifies Aurora Kinase A as a Modulator of Lung Fibrosis.
Journal: American journal of respiratory cell and molecular biology
Published: April 04, 2022
High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD.
Journal: The EMBO journal
Published: March 26, 2022
Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis.
Journal: American journal of respiratory cell and molecular biology
Published: January 17, 2020
FKBP51 modulates steroid sensitivity and NFκB signalling: A novel anti-inflammatory drug target.
Journal: European journal of immunology
Published: May 17, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026